Volume 1, Number 2 (5-2013)                   JPR 2013, 1(2): 80-87 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ghaffari J, Rezaee S A, Gharagozlou M. Chédiak–Higashi syndrome . JPR. 2013; 1 (2) :80-87
URL: http://jpr.mazums.ac.ir/article-1-49-en.html

associate Proffessor Mashhad University of Medical Sciences
Abstract:   (13713 Views)
Chédiak-Higashi syndrome is a rare autosomal recessive congenital immunodeficiency mainly characterized by a condition called oculo-cutaneous albinism. The affected subjects have light-colored hair, vision problems, blood clotting (coagulation) abnormalities and in adulthood varying neurologic disorders. Recurrent infections, particularly viral infection with other disorders in childhood are usually life threatening. It has demonstrated mutations throughout the CHS1/LYST gene. The nature of the mutation can be a predictor of the severity of the disease. The current therapeutic options are: Antibiotics, chemotherapy and bone marrow transplantation. This review will discuss the clinical and molecular aspects of this syndrome for better understanding of the factors that may cause abnormalities.
Full-Text [PDF 286 kb]   (2542 Downloads)    
Type of Study: Narrative Review | Subject: Pediatric Allergology
Received: 2013/05/19 | Accepted: 2013/09/16 | Published: 2013/09/16

Add your comments about this article : Your username or email:
Write the security code in the box

Send email to the article author


© 2015 All Rights Reserved | Journal of Pediatrics Review

Designed & Developed by : Yektaweb